To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·09-18 07:13
      ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 5,960 shares, the number of shares held increased 0.5% compared to the previous period and now represents 8.66% of the total position.
      16Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-18 07:13
      ARKG Investment Tracker position change: Increased position in Freenome, Inc. by 3,576 shares, the number of shares held increased 0.5% compared to the previous period and now represents 0.55% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-18 07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 37,240 shares, the number of shares held increased 0.5% compared to the previous period and now represents 1.23% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-18 07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 4,744 shares, the number of shares held increased 0.5% compared to the previous period and now represents 1.44% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-18 07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 10,820 shares, the number of shares held increased 0.5% compared to the previous period and now represents 2.65% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-18 07:13
      ARKG Investment Tracker position change: Increased position in Eli Lilly by 312 shares, the number of shares held increased 0.49% compared to the previous period and now represents 3.76% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-18 07:13
      ARKG Investment Tracker position change: Increased position in Illumina by 1,780 shares, the number of shares held increased 0.5% compared to the previous period and now represents 4.17% of the total position.
      74Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-18 07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 52,688 shares, the number of shares held increased 0.5% compared to the previous period and now represents 0.74% of the total position.
      467Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-18 07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 7,572 shares, the number of shares held increased 0.5% compared to the previous period and now represents 1.29% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-18 07:13
      ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 8,796 shares, the number of shares held increased 0.5% compared to the previous period and now represents 2.47% of the total position.
      155Comment
      Report
       
       
       
       

      Most Discussed